AKT1 and breast cancer: A recent study shows that, at 10 μM, H-89 is able to inhibit intracellular S. typhimurium growth in the human breast cancer cell line MCF7 and the inhibition of host cell’s Akt1 by H-89 is most likely the attributing factor [35].